Is it safe to prescribe cetirizine to a pregnant woman?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, cetirizine can be safely given to pregnant women

Cetirizine is considered safe for use during pregnancy, with loratadine and cetirizine being the preferred second-generation antihistamines due to their extensive safety data. 1

Evidence-Based Recommendation

The most recent guideline evidence (2020) from the European Respiratory Society/Thoracic Society of Australia and New Zealand explicitly states that loratadine or cetirizine should be preferred as they have been most used during pregnancy 1. This recommendation is based on:

  • No increased risk of congenital malformations: Multiple large-scale studies covering over 186,000 exposures in Scandinavian registries demonstrate no statistically significant associations between second-generation antihistamines and major congenital malformations, spontaneous abortions, or premature births 2

  • Favorable safety profile across all trimesters: H1-antihistamines in general have not been linked to increased risk of congenital anomalies 1, with cetirizine specifically showing safety even with first-trimester exposure 3, 4, 5

Practical Guidance by Trimester

First Trimester (Most Critical Period):

  • Cetirizine is safe to use during organogenesis
  • Most exposures in safety databases occurred during the first trimester without adverse outcomes 3
  • 83.7% of cetirizine-exposed pregnancies resulted in live births 3

Second and Third Trimesters:

  • Continue use as needed
  • Generally considered "probably safe" 1

Important Caveat: One case report (2026) documented fetal supraventricular tachycardia temporally associated with maternal cetirizine use combined with an antihistamine-decongestant in the third trimester 6. However, this was a single case involving combination therapy, not cetirizine alone, and does not outweigh the extensive safety data from large population studies.

Clinical Considerations

  • Breastfeeding: Cetirizine is compatible with breastfeeding, though antihistamines may theoretically reduce milk production 1
  • Dosing: Standard adult dosing applies; no adjustment needed
  • Alternative if needed: Loratadine has equivalent safety profile and can be used interchangeably

What to Avoid

  • Hydroxyzine (cetirizine's parent compound) should be used cautiously in the first trimester based on animal data 7
  • Diphenhydramine, while commonly used, has some association with cleft palate and causes more sedation 7
  • Oral decongestants should be avoided in the first trimester due to associations with gastroschisis and small intestinal atresia 7

The FDA drug label states to "ask a health professional before use" if pregnant 8, which is standard cautionary language, but the clinical evidence strongly supports safety when indicated for allergic conditions.

References

Research

The impact of antihistamine use on allergic reactions in pregnancy.

Drug metabolism and personalized therapy, 2026

Research

Safety of cetirizine in pregnancy.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2018

Research

The fetal safety of cetirizine: an observational cohort study and meta-analysis.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2014

Guideline

the diagnosis and management of rhinitis: an updated practice parameter.

Journal of Allergy and Clinical Immunology, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.